LBA2 Phase II study of PD-L1 expression guidance on neoadjuvant (NA) nivolumab (Nivo) monotherapy with or without platinum-doublet chemotherapy in resectable NSCLC

Saved in:
Bibliographic Details
Published in:Immuno-oncology technology 2022-12, Vol.16, p.100363, Article 100363
Main Authors: Liu, S.-Y., Dong, S., Liao, R.-Q., Jiang, B., Zhang, J.-T., Lin, J.-T., Zhang, S., Yang, J., Nie, Q., Yang, X., Wang, Q., Yan, H.-H., Yan, L., Tu, H., Wang, B.-C., Yang, J.-J., Zhou, Q., Liu, S.-Y.M., Zhong, W.-Z., Wu, Y.-L.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2590-0188
2590-0188
DOI:10.1016/j.iotech.2022.100363